Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Surveys and Questionnaires × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 7 Prostatic Neoplasms 3 Rectal Neoplasms 2 Osteosarcoma 2 Oropharyngeal Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hematologic Neoplasms 2 Depression 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Support of the Family as a Caregiving System 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Pyloric Stenosis, Hypertrophic 1 Peripheral Arterial Disease 1 Ovarian Neoplasms 1 Obesity 1 Newly Diagnosed Cancer of the Oropharynx, Oral Cavity, Colon or Liver 1 Neoplasms 1 Motor Activity 1 Meningioma 1 Melanoma 1 Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System 1 Lymphoma, Large B-Cell, Diffuse 1

Interventions

pembrolizumab 15 enfortumab vedotin 10 Specimen Handling 9 Magnetic Resonance Spectroscopy 9 Nivolumab 7 Carboplatin 5 avelumab 4 Ipilimumab 4 Gemcitabine 4 Docetaxel 4 Cisplatin 4 sacituzumab govitecan 3 Paclitaxel 3 cabozantinib 2 Taxes 2 CTLA-4 Antigen 2 Biopsy 2 zimberelimab 1 zanidatamab 1 tazemetostat 1 soluble LAG-3 protein, human 1 sargramostim 1 sapanisertib 1 relatlimab 1 regorafenib 1 lenvatinib 1 eribulin 1 erdafitinib 1 durvalumab 1 dodecyl maltoside 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡